ANAB - AnaptysBio Inc
IEX Last Trade
38.1
1.480 3.885%
Share volume: 376,929
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$36.62
1.48
4.04%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-08 | 2022-11-08 | 2023-03-01 | 2023-05-11 | 2023-08-07 | 2023-11-02 | 2024-03-11 | 2024-05-09 | |
| Total revenue | 1.216 M | 1.293 M | 6.808 M | 1.374 M | 3.460 M | 3.318 M | 9.005 M | 7.179 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.216 M | 1.293 M | 6.808 M | 1.374 M | 3.460 M | 3.318 M | 9.005 M | 7.179 M | |
| 6.33% | 426.53% | -79.82% | 151.82% | -4.10% | 171.40% | -20.28% | |||
| Operating expenses | 29.015 M | 30.926 M | 32.781 M | 45.775 M | 43.603 M | 41.050 M | 43.801 M | 49.380 M | |
| Selling general and admin | 8.171 M | 8.862 M | 9.407 M | 10.818 M | 10.680 M | 10.172 M | 10.276 M | 12.338 M | |
| Research and development | 20.844 M | 22.064 M | 23.374 M | 34.957 M | 32.923 M | 30.878 M | 33.525 M | 37.042 M | |
| Total expenses | 29.015 M | 30.926 M | 32.781 M | 45.775 M | 43.603 M | 41.050 M | 43.801 M | 49.380 M | |
| 6.59% | 6.00% | 39.64% | -4.74% | -5.86% | 6.70% | 12.74% | |||
| Operating income | -27.799 M | -29.633 M | -25.973 M | -44.401 M | -40.143 M | -37.732 M | -34.796 M | -42.201 M | |
| Ebit | -27.799 M | -29.633 M | -25.973 M | -44.401 M | -40.143 M | -37.732 M | -34.796 M | -42.201 M | |
| Pretax income | -32.554 M | -33.502 M | -26.413 M | -44.255 M | -39.845 M | -37.308 M | -42.215 M | -43.936 M | |
| 2.91% | -21.16% | 67.55% | -9.96% | -6.37% | 13.15% | 4.08% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -4.000 K | 0.000 | |
| Net income basic | -32.554 M | -33.502 M | -26.413 M | -44.255 M | -39.845 M | -37.308 M | -42.211 M | -43.936 M | |
| -2.91% | 21.16% | -67.55% | 9.96% | 6.37% | -13.14% | -4.09% | |||
| Net income | -32.554 M | -33.502 M | -26.413 M | -44.255 M | -39.845 M | -37.308 M | -42.211 M | -43.936 M | |
| -2.91% | 21.16% | -67.55% | 9.96% | 6.37% | -13.14% | -4.09% |